Researchers

  • Asunción Ávila

    Vascular risk

    Phd
  • Luis Miguel Ceresuela

    Vascular risk

  • Manuel Jesús Gómez-choco

    Vascular risk

    Phd
  • Montserrat Martín-baranera

    Vascular risk

    Phd
  • Pedro Armario

    Vascular risk

    Phd
  • Peter Blanch

    Vascular risk

    Phd
  • Rachel Hernandez

    Vascular risk

    Phd

Contact the group

Form

Projects

  • Vascular risk

    Researcher
    • Year 2016
    • Hospital General de l'Hospitalet

    National Heart Failure Registry (RICA),

    • DISTRICT ATTORNEY:

      Spanish Society of Internal Medicine - Group of IC and FA

    • TYPE E:

      PI

    • Year 2016
    • Sant Joan Despí Moisès Broggi Hospital

    Bilingualism as a cognitive reserve factor in normal and pathological aging,

    • DISTRICT ATTORNEY:

      Pompeu Fabra University - Mr. Albert Costa

    • TYPE E:

      PINE TREE

    • Year 2016
    • Sant Joan Despí Moisès Broggi Hospital

    Prognostic value of cerebral hemodynamics measured by 24-hour ambulatory blood pressure monitoring in the progression of small-vessel disease after a first lacunar stroke,

    • DISTRICT ATTORNEY:

      Dr. Manuel Jesús Gómez Choco

    • TYPE E:

      PINE TREE

    • Year 2016
    • Sant Joan Despí Moisès Broggi Hospital

    Hospital epidemiological survey on Advanced Heart Failure,

    • DISTRICT ATTORNEY:

      Spanish Society of Internal Medicine

    • TYPE E:

      PINE TREE

    • Year 2016
    • Sant Joan Despí Moisès Broggi Hospital

    Superiority study, phase III, multicenter, randomized, double blind, double simulation, with active comparator and directed by events, which compares rivaroxaban 15 mg once daily with aspirin 100 mg, in the secondary prevention of cerebrovascular accident and systemic embolism in patients who have recently suffered an embolic cerebrovascular accident of undetermined etiology (ACEI). (NAVIGATE ESUS)

    • DISTRICT ATTORNEY:

      Bayer Healthcare AG.

    • TYPE E:

      RD2015

    • Year 2016
    • Sant Joan Despí Moisès Broggi Hospital

    Descriptive observational study of convenience in patients treated with dabigatran for the prevention of stroke in non-valvular atrial fibrillation. RESONANCE,

    • TYPE E:

      EPA

    • Year 2016
    • L'Hospitalet General Hospital

    National Heart Failure Registry (RICA),

    • DISTRICT ATTORNEY:

      Spanish Society of Internal Medicine - Group of IC and FA

    • TYPE E:

      PINE TREE

    • Year 2016
    • L'Hospitalet General Hospital

    Non-interventional prospective study of patients with mild to moderate Alzheimer's disease and their caregivers in four European countries,

    • DISTRICT ATTORNEY:

      Merck Sharp & Dohme Corp.

    • TYPE E:

      EPA

  • Vascular risk

    Researcher
    • Year 2015
    • Hospital General de l'Hospitalet

    COPPADIS-15 Cohort of Patients with Parkinson's Disease in Sapain,

    • DISTRICT ATTORNEY:

      from the Spanish Foundation for Parkinson's Research

    • TYPE E:

      EPA

  • Vascular risk

    Researcher
    • Year 2015
    • Sant Joan Despí Moisès Broggi Hospital

    Multicentric, observational study to determine the profile and management of antithrombotic treatment in patients with non-valvular atrial fibrillation who attend the internal medicine services of Spanish hospitals (PROFILE STUDY),

    • DISTRICT ATTORNEY:

      Bristol-Myers Squibb SAU

    • TYPE E:

      EPA

Lines of action

  • Resistant hypertension and refractory hypertension
  • Arterial stiffness in hypertension and cerebrovascular disease
  • Small vessel cerebrovascular disease: Lacunar infarction
  • Factors associated with stroke recurrences
  • Thrombolytic treatment and acute stroke care circuits
  • Prognostic value of premorbid BP and BP in the acute phase of stroke

Documents

Information of interest

Links